Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating women who have breast cancer that is metastatic or cannot be treated with surgery.

Key facts

Study ID

NCT00015886

Run by

Wake Forest University Health Sciences

People needed

25

Starts

1997-01-01

Expected to finish

2009-07-01

Last updated by the study team

2018-08-13

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Southeastern Medical Oncology Center — Goldsboro, North Carolina, United States
• East Carolina University School of Medicine — Greenville, North Carolina, United States
• Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
• Cancer Centers of the Carolinas — Greenville, South Carolina, United States
• Palmetto Hematology/Oncology Associates — Spartanburg, South Carolina, United States
• Massey Cancer Center — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.